| Accountable Medication Management in Drug and Alcohol Services
|
SESLHDBR/077 |
|
| Apprehended Violence Orders (AVO): Health Staff Responsibilities
|
SESLHDPD/309 |
|
| Authorisation process for placing conditions on a clients access to treatment.
|
SESLHDBR/066 |
Under Review |
| Buprenorphine subcutaneous depot injection (Buvidal®) for opioid dependence
|
SESLHDPR/652 |
|
| Clinical Nurse Specialist (CNS) Grade 1 Appointment and Review Process
|
SESLHDBR/053 |
|
| Clinical Supervision for Drug and Alcohol Service Clinical Staff
|
SESLHDBR/075 |
|
| Drug and Alcohol - Management of missed consecutive doses: Methadone and buprenorphine/buprenorphine - naloxone
|
SESLHDPR/411 |
|
| Drug and Alcohol - Management of the Unconscious Person
|
SESLHDPR/616 |
|
| Drug and Alcohol Service – Management of intoxicated clients presenting to community treatment settings of the Drug and Alcohol Service
|
SESLHDPR/506 |
|
| Drug and Alcohol – Inpatient Management of Alcohol Withdrawal
|
SESLHDPR/238 |
|
| Follow up pathways after client does not attend (DNA) an appointment or treatment
|
SESLHDBR/070 |
Under Review |
| Medication Supply in Drug and Alcohol Services
|
SESLHDPR/485 |
|
| Pain Management - Opioid Withdrawal in Patients on Long Term Opioid Medications
|
SESLHDPR/603 |
|
| Process for arranging emergency and elective Drug and Alcohol (D&A) admissions to Sydney / Sydney Eye Hospital (SSEH)
|
SESLHDBR/060 |
|
| Submission of Conference Abstracts by SESLHD Drug and Alcohol staff
|
SESLHDBR/45 |
|
| Take-home naloxone under the Opioid Overdose Response and Take Home Naloxone (ORTHN) intervention (Nyxoid® or Prenoxad®)
|
SESLHDPR/658 |
|
